Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cryo Technique Enables Scientists to See Brain Tumor Cell Migration

By HospiMedica International staff writers
Posted on 08 Sep 2011
For the first time, scientists can see pathways to stop a lethal brain cancer from spreading. More...
Researchers have imaged individual cancer cells and the pathways they move as the tumor metastasizes. The researchers used an innovative cryoimaging technique to obtain the first-time look at a mouse model of glioblastoma multiforme (GBM), an especially aggressive cancer that has no treatments to stop it from metastasizing.

The study’s findings were published September 1, 2011, in the journal Cancer Research. “We’re able to see things we couldn’t before, and we can use these images to understand how tumor cells invade and disperse,” said Susann M. Brady-Kalnay, a professor of molecular biology and microbiology at the Case Western Reserve School of Medicine (Cleveland, OH, USA), and senior author of the study. That data, in turn, can be used to help develop and assess the effectiveness of drugs and other therapies used to treat the cancer, she said.

To obtain the view, the scientists used a model that included four different cell lines of brain cancers at various stages of tumor development and dispersion. The cancer cells were modified with fluorescent markers and implanted in the model’s brain in collaboration with biomedical engineering Prof. James Basilion’s lab. The cryoimaging system, developed by Dr. David Wilson, also a professor of biomedical engineering at Case Western Reserve, disassembles the brain layer by layer and reassembles the model into a color three-dimensional (3D) digital image.

Utilizing software and algorithms designed by the researchers, the scientists are able to differentiate the main tumor mass, the blood vessels that feed the cancer and dispersing cells. The imaging system enables them to peer at single cells and see exactly where they are in the brain. The lead researchers, Susan Burden-Gulley, Mohammed Qutaish, and Kristin Sullivant, found that two cell lines, a human brain cancer LN229, and a rodent cancer CNS-1, best resemble the actions of GBM in human patients.

Reconstructions of models of those two lines enabled the researchers to examine the extent and patterns of cancer cell migration and dispersal from tumors along blood vessels and white matter tracts within the brain. The ability to generate such clear and detailed images, according to the researchers, will be instrumental when evaluating the effectiveness of drugs and other therapies designed to block dispersal of glioblastoma multiforme cells.

Related Links:
Case Western Reserve School of Medicine




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.